Medication Use
Seek guidance if you use nitrates, blood thinners, anticoagulants, antiplatelet drugs, blood-pressure medication, diabetes medication or prescription ED medication.
Safety
Boostaro Safety and Responsible Use
Interactions, Cautions and Label Guidance
Boostaro safety starts with the label, your health history and medication fit. This page explains dietary-supplement status, ingredient-specific cautions and clear limits of the information provided here.
Last reviewed: August 5, 2026
Supplement status
Boostaro Is a Dietary Supplement
Boostaro is not a prescription medication, ED drug, cardiovascular treatment or emergency product. Dietary supplement statements are not evaluated like drug claims and should not be used to diagnose, treat, cure or prevent disease.
Use the ingredients page to review the current formula and the FDA disclaimer for the supplement notice.
Before use
Who Should Seek Professional Advice
Ask a qualified healthcare professional before using Boostaro if any of these situations apply.
Medical Conditions
Ask first if you have heart, kidney, liver, bleeding, clotting, blood-pressure, blood-sugar or complex chronic health concerns.
Planned Surgery or Procedures
Discuss supplement use before surgery, dental procedures or procedures where bleeding risk matters.
Allergies or Sensitivities
Review all listed ingredients and capsule materials. Nattokinase is commonly soy-derived, so people with soy concerns should be especially careful.
Ingredient cautions
Key Boostaro Safety Considerations
Nattokinase and Bleeding-Related Cautions
Nattokinase is discussed in circulation-related supplement contexts and may not be appropriate with blood thinners, anticoagulants, antiplatelet drugs, bleeding disorders or surgery-related instructions.
Vitamin K and Anticoagulant Considerations
Vitamin K intake can matter for people using warfarin or similar anticoagulant therapy. Do not change supplemental Vitamin K intake without professional guidance if this applies to you.
L-Citrulline, Blood Pressure and Nitrates
L-Citrulline is discussed in nitric oxide pathway contexts. People using nitrates, blood-pressure medication or prescription ED drugs should seek professional advice before use.
Magnesium Considerations
Supplemental magnesium can cause digestive effects and may be unsuitable for some people with kidney disease or medication restrictions.
General Allergy Guidance
Stop use and seek help if you experience signs of an allergic reaction, such as swelling, trouble breathing, rash, hives or severe discomfort.
When to Stop Use
Stop using Boostaro and seek medical help for chest pain, fainting, severe dizziness, unusual bleeding, severe allergic symptoms, or any serious or unexpected reaction.
Clear Limits of This Information
This page is general product-safety information. It cannot account for your medical history, medication list, lab results or clinician instructions.
Boostaro formula
Boostaro Ingredients
Check the formula, label facts and safety cautions before opening checkout.
References
Boostaro Safety References
These sources support ingredient roles, safety cautions and supplement-language limits. They do not prove a predictable result from the complete Boostaro formula. Proprietary-blend ingredients share a 725 mg total, so individual doses cannot be compared directly with study doses.
Dietary supplement statusFDA dietary supplement guidance
Supports describing Boostaro as a dietary supplement, not as a drug or disease treatment.
Health-claim wordingFTC health-product advertising guidance
Supports using qualified structure-function language instead of guaranteed medical outcomes.
Vitamin C roleNIH ODS Vitamin C fact sheet
Supports antioxidant and collagen-formation wording; does not prove a Boostaro finished-product result.
Vitamin K cautionNIH ODS Vitamin K fact sheet
Supports anticoagulant/warfarin caution language.
Magnesium roleNIH ODS Magnesium fact sheet
Supports normal muscle, nerve and energy-related body-process wording.
L-Citrulline contextPubMed-indexed L-Citrulline review
Supports cautious nitric-oxide pathway context without promising blood-pressure or ED treatment.
Pine Bark Extract contextPubMed-indexed pine bark extract research
Supports ingredient-level antioxidant/endothelial context only. Pycnogenol evidence is not Boostaro evidence unless equivalence is verified.
Nattokinase cautionPubMed-indexed nattokinase reviews
Supports circulation-related context and blood-thinner/surgery caution.
- FDA: Dietary Supplement Products & IngredientsDietary supplement regulation
Explains that dietary supplements are regulated differently from drugs and should not be framed as disease treatments authorized like drugs.
- FDA: Tainted Sexual Enhancement and Energy ProductsSexual-enhancement safety
Supports cautious language around sexual-enhancement supplement safety and hidden-drug concerns.
- NIH ODS: Vitamin K Fact SheetVitamin K
Supports Vitamin K caution language for warfarin and similar anticoagulants.
- NIH ODS: Magnesium Fact SheetMagnesium
Supports magnesium wording for normal muscle, nerve, blood-pressure and energy-related body processes.
- PubMed: L-Citrulline and Exercise Performance ReviewL-Citrulline context
Supports discussing L-Citrulline as ingredient-level nitric-oxide pathway context; it does not establish a Boostaro finished-product outcome.
- PubMed Central: Nattokinase ReviewNattokinase
Supports cautious circulation-related context and the need to avoid disease-treatment or clot-removal claims.
- PubMed: Nattokinase Oral Antithrombotic Agent ReviewNattokinase
Supports special caution around fibrinolytic and anticoagulant-related activity.